 |
市场调查报告书
商品编码
1547586
全球抗凝血逆转药物市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测Global Anticoagulant Reversal Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
||||||
全球抗凝血逆转药物市场需求预计将从 2023 年的 123128 万美元达到 2032 年近 427086 万美元的市场规模，2024-2032 年研究期间复合年增长率为 14.82%。
抗凝血逆转药物是用于抵消抗凝血药物影响的药物，例如直接口服抗凝血剂 (DOAC) 和华法林，特别是在出血紧急情况或需要快速逆转抗凝血药物时（例如手术前）。这些药物透过促进血栓形成或抑制抗凝血剂的活性来帮助止血。常用的抗凝血逆转剂包括维生素 K、凝血酶原复合物浓缩物 (PCC) 和 DOAC 的特异性逆转剂，例如用于达比加群的 idarucizumab 和用于 Xa 因子抑制剂的 andexanet alfa。
市场动态
心血管疾病盛行率的增加、外科手术数量的增加以及抗凝血治疗的进步等因素推动了抗凝血逆转药物市场的发展。心血管疾病通常需要抗凝血治疗来预防血栓，但这些治疗可能会导致併发症，需要使用抗凝血逆转药物。老年人口的增加，更容易罹患心血管疾病，也增加了这些药物的需求。此外，择期手术和急诊手术数量的不断增加，需要有效的抗凝血逆转剂来控製手术期间和手术后的出血风险。抗凝血药物的创新促进了新型逆转剂的开发，改善了患者的治疗效果并推动了市场成长。已开发和发展中地区的监管批准和医疗保健支出的增加进一步支持了市场扩张。然而，安全问题和临床应用有限可能会阻碍未来几年抗凝血逆转药物市场的成长。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球抗凝血逆转药物市场的各个细分市场进行了包容性评估。抗凝血逆转药物产业的成长和趋势为本研究提供了整体方法。
市场区隔
抗凝血逆转药物市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。
依产品类型
- 凝血酶原复合物浓缩物
- 植物萘二酮
- 安德萨内特阿尔法
- 伊达赛珠单抗
- 鱼精蛋白
- 其他的
按配销通路
- 医院药房
- 零售药房
- 网路药房
区域分析
本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲抗凝血逆转药物市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。抗凝血逆转药物市场的主要参与者包括Portola Pharmaceuticals、勃林格殷格翰、CSL Behring、Bausch Health Companies Inc.、Octapharma AG、Dr. Reddy'S Laboratories、AMAG Pharmaceuticals Inc.、辉瑞公司、SGPharma Pvt.有限公司、阿尔卑斯製药工业股份有限公司、费森尤斯卡比股份公司。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
目录
第一章：前言
- 报告说明
- 客观的
- 目标受众
- 独特的销售主张 (USP) 和产品
- 研究范围
- 研究方法
- 市场研究过程
- 市场研究方法论
第 2 章：执行摘要
- 市集亮点
- 全球市场概况
第 3 章：抗凝血逆转药物 - 产业分析
- 简介 - 市场动态
- 市场驱动因素
- 市场限制
- 机会
- 产业动态
- 波特五力分析
- 市场吸引力分析
- 市场吸引力分析：按产品类型
- 按配销通路分類的市场吸引力分析
- 市场吸引力分析：按地区
第 4 章：价值链分析
- 价值链分析
- 原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
- 潜在买家名单
- 行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势
第 5 章：全球抗凝血逆转药物市场分析：依产品类型
- 概述：按产品类型
- 历史与预测资料分析：按产品类型
- 凝血酶原复合物浓缩物
- 植物萘二酮
- 安德萨内特阿尔法
- 伊达赛珠单抗
- 鱼精蛋白
- 其他的
第 6 章：全球抗凝血逆转药物市场分析：按分销管道
- 配销通路概述
- 按配销通路进行历史和预测资料分析
- 医院药房
- 零售药房
- 网路药房
第 7 章：全球抗凝血逆转药物市场分析：依地理位置
- 区域展望
- 介绍
- 北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
- 欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
- 亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
- 拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
- 中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析
第 8 章：抗凝血逆转药物公司的竞争格局
- 抗凝血逆转药物市场竞争
- 伙伴关係/协作/协议
- 併购
- 新产品发布
- 其他发展
第 9 章：公司简介
- 顶级公司市占率分析
- 市场集中度
- Portola Pharmaceuticals
- 公司概况
- 公司收入
- 产品
- 最新动态
- Boehringer Ingelheim
- 公司概况
- 公司收入
- 产品
- 最新动态
- CSL Behring
- 公司概况
- 公司收入
- 产品
- 最新动态
- Bausch Health Companies Inc.
- 公司概况
- 公司收入
- 产品
- 最新动态
- Octapharma AG
- 公司概况
- 公司收入
- 产品
- 最新动态
- Dr. Reddy'S Laboratories
- 公司概况
- 公司收入
- 产品
- 最新动态
- AMAG Pharmaceuticals Inc.
- 公司概况
- 公司收入
- 产品
- 最新动态
- Pfizer Inc.
- 公司概况
- 公司收入
- 产品
- 最新动态
- SGPharma Pvt. Ltd.
- 公司概况
- 公司收入
- 产品
- 最新动态
- Alps Pharmaceutical Ind. Co. Ltd.
- 公司概况
- 公司收入
- 产品
- 最新动态
- Fresenius Kabi AG
- 公司概况
- 公司收入
- 产品
- 最新动态
註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内
The global demand for Anticoagulant Reversal Drugs Market is presumed to reach the market size of nearly USD 4270.86 Million by 2032 from USD 1231.28 Million in 2023 with a CAGR of 14.82% under the study period 2024-2032.
Anticoagulant reversal drugs are medications used to counteract the impact of anticoagulant medications, such as direct oral anticoagulants (DOACs) and warfarin, particularly in bleeding emergencies or when rapid reversal of anticoagulation is necessary, such as before surgery. These drugs work by promoting clot formation or inhibiting the activity of anticoagulants to help stop bleeding. Commonly used anticoagulant reversal agents include vitamin K, prothrombin complex concentrates (PCCs), and specific reversal agents for DOACs, such as idarucizumab for dabigatran and andexanet alfa for factor Xa inhibitors.
MARKET DYNAMICS
Factors including the increasing prevalence of cardiovascular diseases, the growing number of surgical procedures, and advancements in anticoagulant therapies drive the anticoagulant reversal drugs market. Cardiovascular diseases often require anticoagulant treatments to prevent blood clots, but these treatments can lead to complications requiring the use of anticoagulant reversal drugs. The increasing elderly population, who are more susceptible to cardiovascular conditions, also contributes to the demand for these drugs. Additionally, the rising number of surgeries, both elective and emergency, necessitates the availability of effective anticoagulant reversal agents to manage bleeding risks during and after procedures. Innovations in anticoagulant drugs have led to the development of new reversal agents, improving patient outcomes and driving market growth. Regulatory approvals and increasing healthcare expenditures in developed and developing regions further support the market expansion. However, safety concerns and limited adoption in clinical settings may hinder the growth of the anticoagulant reversal drugs market in the next few years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Anticoagulant Reversal Drugs. The growth and trends of Anticoagulant Reversal Drugs industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Anticoagulant Reversal Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
- Prothrombin Complex Concentrates
- Phytonadione
- Andexanet Alfa
- Idarucizumab
- Protamine
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Anticoagulant Reversal Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Anticoagulant Reversal Drugs market include Portola Pharmaceuticals, Boehringer Ingelheim, CSL Behring, Bausch Health Companies Inc., Octapharma AG, Dr. Reddy'S Laboratories, AMAG Pharmaceuticals Inc., Pfizer Inc., SGPharma Pvt. Ltd., Alps Pharmaceutical Ind. Co. Ltd., Fresenius Kabi AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. ANTICOAGULANT REVERSAL DRUGS - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET ANALYSIS BY PRODUCT TYPE
- 5.1. Overview By Product Type
- 5.2. Historical and Forecast Data Analysis By Product Type
- 5.3. Prothrombin Complex Concentrates Historic and Forecast Sales By Regions
- 5.4. Phytonadione Historic and Forecast Sales By Regions
- 5.5. Andexanet Alfa Historic and Forecast Sales By Regions
- 5.6. Idarucizumab Historic and Forecast Sales By Regions
- 5.7. Protamine Historic and Forecast Sales By Regions
- 5.8. Others Historic and Forecast Sales By Regions
6. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
- 6.1. Overview By Distribution Channel
- 6.2. Historical and Forecast Data Analysis By Distribution Channel
- 6.3. Hospital Pharmacy Historic and Forecast Sales By Regions
- 6.4. Retail Pharmacy Historic and Forecast Sales By Regions
- 6.5. Online Pharmacy Historic and Forecast Sales By Regions
7. GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET ANALYSIS BY GEOGRAPHY
- 7.1. Regional Outlook
- 7.2. Introduction
- 7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
- 7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
- 7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
- 7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
- 7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis
8. COMPETITIVE LANDSCAPE OF THE ANTICOAGULANT REVERSAL DRUGS COMPANIES
- 8.1. Anticoagulant Reversal Drugs Market Competition
- 8.2. Partnership/Collaboration/Agreement
- 8.3. Merger And Acquisitions
- 8.4. New Product Launch
- 8.5. Other Developments
9. COMPANY PROFILES OF ANTICOAGULANT REVERSAL DRUGS INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Market Concentration Rate
- 9.3. Portola Pharmaceuticals
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
- 9.4. Boehringer Ingelheim
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
- 9.5. CSL Behring
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
- 9.6. Bausch Health Companies Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
- 9.7. Octapharma AG
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
- 9.8. Dr. Reddy'S Laboratories
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
- 9.9. AMAG Pharmaceuticals Inc.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
- 9.10. Pfizer Inc.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
- 9.11. SGPharma Pvt. Ltd.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
- 9.12. Alps Pharmaceutical Ind. Co. Ltd.
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
- 9.13. Fresenius Kabi AG
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers: Impact Analysis
- Restraints: Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- Analysis By Product Type (USD MN)
- Prothrombin Complex Concentrates Market Sales By Geography (USD MN)
- Phytonadione Market Sales By Geography (USD MN)
- Andexanet Alfa Market Sales By Geography (USD MN)
- Idarucizumab Market Sales By Geography (USD MN)
- Protamine Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Analysis By Distribution Channel (USD MN)
- Hospital Pharmacy Market Sales By Geography (USD MN)
- Retail Pharmacy Market Sales By Geography (USD MN)
- Online Pharmacy Market Sales By Geography (USD MN)
- Global Anticoagulant Reversal Drugs Market Sales By Geography (USD MN)
- North America Market Analysis (USD MN)
- United States Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate By Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Anticoagulant Reversal Drugs Report
- Market Research Process
- Market Research Methodology
- Global Anticoagulant Reversal Drugs Market Size, By Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis By Product Type
- Market Attractiveness Analysis By Distribution Channel
- Market Attractiveness Analysis By Region
- Value Chain Analysis
- Global Market Analysis By Product Type (USD MN)
- Prothrombin Complex Concentrates Market Sales By Geography (USD MN)
- Phytonadione Market Sales By Geography (USD MN)
- Andexanet Alfa Market Sales By Geography (USD MN)
- Idarucizumab Market Sales By Geography (USD MN)
- Protamine Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Market Analysis By Distribution Channel (USD MN)
- Hospital Pharmacy Market Sales By Geography (USD MN)
- Retail Pharmacy Market Sales By Geography (USD MN)
- Online Pharmacy Market Sales By Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
